Dr. Daryl Gohl of the University of Minnesota Genomics Center, former CSO and founder of CoreBiome and current senior advisor to Diversigen, throughout his career has developed best practices for microbiome sequencing. In August 2019, Dr. Gohl had the opportunity to present at the National Institute of Standards and Technology

Diversigen and CoreBiome, DNA Genotek’s microbiome services sister companies, have combined their offerings under the Diversigen name. The rebrand highlights the combined companies’ unparalleled scientific bench strength, state-of-the-art laboratory, ability to translate data to insights and collective focus on quality and service. The unified Diversigen operation will continue to offer

Below we’re sharing results from the validation study scientists at Diversigen and DNA Genotek undertook to ensure Diversigen’s viral metagenomics capabilities could be leveraged to help during the COVID-19 pandemic.  “When I was a boy and I would see scary things in the news, my mother would say to me,

As the microbiome industry grows and evolves, so has our team of microbiome experts. In 2019, DNA Genotek’s parent company, OraSure, acquired both CoreBiome and Diversigen. Through these acquisitions, we gained Diversigen’s industry recognized CLIA/CAP state-of-the-art techniques with expert consultative microbiome services, and the strength of CoreBiome’s innovative scalable sequencing technology.  In

Strategies in microbiome sequencing By Shanda Giacomoni on Jan 16, 2020 1:15:00 PM Choosing the best sequencing platform for your research There are many ways to profile a microbiome: Amplicon (16S) sequencing, shallow shotgun or deep shotgun. Each platform has its own strengths and limitations that can influence your study design. Dr. Tonya